| Application no. and date | 00946614.5 (espacenet) (Federated) (European Patent Register), 20000620 | | Patent/reg. no. and date | DK/EP 1191926, 20050330 | | Publication date | 20020403 | | Priority no. and date | SE 9902386, 19990622 | | EP pub. no. and date |
EP 1191926 20020403 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | SJÖBLOM, Brita, AstraZeneca R & D Mölndal
S-431 83 Mölndal, SE,
LUNDBERG, Per, Johan, AstraZeneca R&D Mölndal
S-431 83 Mölndal, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61K 9/36 (2006.01) , A61P 1/04 (2006.01) | | Title | Ny omeprazol- og (S)-omeprazolformulering | | Int. application no. | SE2000001310 | | Int. publication no. | WO2000078293 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
